Michelle Mullins, MD
Sports Medicine · Orlando, FLNPI 1902334816
Payments from drug & device makers
Across 22 payments — averaging $20.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Ferring Pharmaceuticals Inc.$69
- Molnlycke Health Care US, LLC$54
- Vertex$44
- Heron Therapeutics, Inc.$43
- Endo Pharmaceuticals Inc.$43
- Embody, Inc.$33
- plus $176 from 10 others
What the payments were for
- Food & beverage$461100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Ferring Pharmaceuticals Inc. | 3 | $69 |
| Molnlycke Health Care US, LLC | 2 | $54 |
| Vertex | 2 | $44 |
| Heron Therapeutics, Inc. | 1 | $43 |
| Endo Pharmaceuticals Inc. | 2 | $43 |
| Embody, Inc. | 2 | $33 |
| Orthofix Medical, Inc. | 1 | $24 |
| Bioventus LLC | 1 | $23 |
| KCI USA, Inc. | 1 | $18 |
| Sanofi-aventis U.S. LLC | 1 | $18 |
| Zimvie Inc. | 1 | $17 |
| Radius Health, Inc. | 1 | $17 |
| Theragen, Inc. | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Joint Active Systems, Inc. | 1 | $14 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
How this compares
$461 in reported general payments places this provider in the 30th percentile of 402 sports medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Celecoxib | 16 | $611 |
| Cyclobenzaprine Hcl | 58 | $322 |
| Methylprednisolone | 37 | $293 |
| Meloxicam | 131 | $272 |
| Ibuprofen | 12 | $135 |
| Diclofenac Sodium | 11 | $65 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in Orlando
- Bruce LevyOrlando$816K
- Andrew CarboneOrlando$90K
- Abhishek KannanOrlando$33K
- Kyle CoxOrlando$29K
- Callie JewettOrlando$23K
- Lee KaplanMiami$11.3M
- Patrick SmithNaples$3.7M
- Ryan SimovitchWest Palm Beach$1.1M
- Adam AnzGulf Breeze$960K
- Gautam YagnikMiami$458K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.